Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice J Xiong, I Deng, S Kelliny, L Lin, L Bobrovskaya, XF Zhou Metabolic Brain Disease 37 (6), 1941-1957, 2022 | 16 | 2022 |
A new approach to model sporadic Alzheimer’s disease by intracerebroventricular streptozotocin injection in APP/PS1 mice S Kelliny, L Lin, I Deng, J Xiong, F Zhou, M Al-Hawwas, L Bobrovskaya, ... Molecular Neurobiology 58, 3692-3711, 2021 | 12 | 2021 |
Peripheral ProBDNF delivered by an AAV vector to the muscle triggers depression-like behaviours in mice LY Lin, S Kelliny, LC Liu, M Al-Hawwas, XF Zhou, L Bobrovskaya Neurotoxicity Research 38, 626-639, 2020 | 8 | 2020 |
Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of Alzheimer’s disease, in Sprague Dawley rats S Kelliny, HY Lam, A Parikh, YJ Wang, L Bobrovskaya, R Upton, XF Zhou Current Drug Metabolism 21 (3), 235-244, 2020 | 7 | 2020 |
Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia S Kelliny, J Xiong, L Bobrovskaya, XF Zhou Neurotoxicity Research 39, 1689-1707, 2021 | 4 | 2021 |
Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats S Kelliny, L Bobrovskaya, XF Zhou, R Upton European Journal of Drug Metabolism and Pharmacokinetics 46, 235-248, 2021 | 1 | 2021 |
Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice S Kelliny, I Deng, XF Zhou, L Bobrovskaya Handbook of Animal Models in Neurological Disorders, 17-30, 2023 | | 2023 |
A Novel Oral Edaravone Formulation Partially Alleviates Tau Pathology and Motor Deficits in an Animal Model of Frontotemporal Dementia S Kelliny, J Xiong, L Bobrovskaya, XF Zhou | | 2021 |